Update shared on08 Aug 2025
Fair value Increased 12%Vital Farms’ consensus price target has increased to $50.10, driven by improved profitability as reflected in a higher net profit margin and strengthening valuation supported by a lower future P/E.
What's in the News
- Raised full-year 2025 net revenue guidance to at least $770 million, representing 27% year-over-year growth.
- Surpassed 500 family farms in network, up from 300 at end of 2023, and investing in expanded supply chain capacity and two major eggwashing/packing facilities.
- Removed from multiple Russell indexes, including Russell 3000E and Russell Microcap.
- Stockholders approved an amendment limiting officer liability to the maximum extent permitted by Delaware law, excluding breaches of duty of loyalty, bad faith, intentional misconduct, or personal benefit.
Valuation Changes
Summary of Valuation Changes for Vital Farms
- The Consensus Analyst Price Target has risen from $45.90 to $50.10.
- The Net Profit Margin for Vital Farms has risen from 8.13% to 8.60%.
- The Future P/E for Vital Farms has fallen from 30.52x to 28.93x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.